Insider · CIK 0001579247

Bolte Axel

Reports to the SEC for 5 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001579247

Forms 4 and 5

Insider transactions

48 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-07-01	Inozyme Pharma, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−234K sh	—	—	0
2025-07-01	Inozyme Pharma, Inc.U Disposition from Tender	Director	UDisposition from Tender	−424K sh	$4.00	−$1.7M	0
2025-07-01	Inozyme Pharma, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−159K sh	—	—	0
2025-05-15	Inozyme Pharma, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+4,407 sh	$0.98	+$4,318.86	423,926
2025-05-15	Inozyme Pharma, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+153K sh	$0.98	+$150K	419,519
2025-05-15	Inozyme Pharma, Inc.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,407 sh	—	—	0
2025-05-15	Inozyme Pharma, Inc.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−153K sh	—	—	0
2024-06-18	Inozyme Pharma, Inc.Stock Option (right to buy)A Award	Director	AAward	+28K sh	—	—	28,000
2023-07-11	IVERIC bio, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−22.1K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−7,500 sh	—	—	0
2023-07-11	IVERIC bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15.5K sh	—	—	0
2023-07-11	IVERIC bio, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−23.2K sh	—	—	0
2023-06-13	Inozyme Pharma, Inc.Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2023-05-17	IVERIC bio, Inc.Restricted Stock UnitsA Award	Director	AAward	+7,500 sh	—	—	7,500
2023-05-11	IVERIC bio, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−14.6K sh	—	—	0
2023-05-11	IVERIC bio, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+14.6K sh	—	—	22,088
2023-05-01	Inozyme Pharma, Inc.Stock option (right to buy)A Award	Director	AAward	+100K sh	—	—	100,000
2023-03-31	Inozyme Pharma, Inc.A Award	Director	AAward	+4,806 sh	$2.21	+$10.6K	266,696
2022-09-30	Inozyme Pharma, Inc.A Award	Director	AAward	+3,315 sh	$2.28	+$7,558.2	261,890
2022-05-12	IVERIC bio, Inc.Restricted Stock UnitsA Award	Director	AAward	+14.6K sh	—	—	14,588
2022-05-12	IVERIC bio, Inc.Stock Option (right to buy)A Award	Director	AAward	+23.2K sh	—	—	23,186
2022-05-11	IVERIC bio, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+7,500 sh	—	—	7,500
2022-05-11	IVERIC bio, Inc.Restricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−7,500 sh	—	—	0
2022-04-19	Inozyme Pharma, Inc.P Purchase	Director	PPurchase	+67.8K sh	$3.69	+$250K	258,575
2022-02-24	Inozyme Pharma, Inc.Stock option (right to buy)A Award	Director	AAward	+275K sh	—	—	275,000
2021-06-24	Inozyme Pharma, Inc.S Sale	Director	SSale	−66.8K sh	$0.00	−$6.679	190,825
2021-06-24	Inozyme Pharma, Inc.Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−66.8K sh	—	—	100,480
2021-06-24	Inozyme Pharma, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+66.8K sh	$0.98	+$65.5K	257,613
2021-05-19	IVERIC bio, Inc.Restricted Stock UnitsA Award	Director	AAward	+7,500 sh	—	—	7,500
2021-05-19	IVERIC bio, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+15.5K sh	—	—	15,500
2021-03-04	Inozyme Pharma, Inc.Stock option (right to buy)A Award	Director	AAward	+117K sh	—	—	117,000
2021-01-13	Inozyme Pharma, Inc.Stock option (right to buy)A Award	Director	AAward	+66.8K sh	—	—	66,788
2021-01-13	Inozyme Pharma, Inc.Stock Option (right to buy)A Award	Director	AAward	+159K sh	—	—	159,187
2020-07-23	Inozyme Pharma, Inc.Stock Option (right to buy)A Award	Director	AAward	+288K sh	—	—	287,706
2020-06-09	IVERIC bio, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+16K sh	—	—	16,000
2019-05-15	IVERIC bio, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+16K sh	—	—	16,000
2018-06-08	Allena Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10.2K sh	—	—	10,182
2018-05-23	IVERIC bio, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+16K sh	—	—	16,000
2017-05-19	IVERIC bio, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+16K sh	—	—	16,000
2016-12-30	IVERIC bio, Inc.S Sale	Director	SSale	−6,000 sh	$4.83	−$29K	0
2016-06-03	IVERIC bio, Inc.P Purchase	Director	PPurchase	+3,500 sh	$56.97	+$199K	6,000
2015-03-30	IVERIC bio, Inc.P Purchase	Director	PPurchase	+500 sh	$48.27	+$24.1K	2,500
2013-09-25	IVERIC bio, Inc.P Purchase	Director	PPurchase	−2,000 sh	$22.00	−$44K	2,000
2013-06-25	PTCTPTC THERAPEUTICS, INC.P Purchase	Director	PPurchase	+20K sh	$15.00	+$300K	20,000

Recent filings

Accepted (ET)
Jul 34
Bolte Axel0000950170-25-094096
SEC(opens sec.gov)
May 204
Bolte Axel0000950170-25-075148
SEC(opens sec.gov)
Jun 204
Bolte Axel0000950170-24-075575
SEC(opens sec.gov)
Jul 134
Bolte Axel0001104659-23-080679
SEC(opens sec.gov)
Jun 154
Bolte Axel0001209191-23-037294
SEC(opens sec.gov)
May 194
Bolte Axel0001410939-23-000089
SEC(opens sec.gov)
May 154
Bolte Axel0001410939-23-000077
SEC(opens sec.gov)

Companies

Address

C/O OPHTHOTECH CORPORATION ONE PENN PLAZA, 35TH FLOOR

NEW YORK, NY, 10119